Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AtriCure Inc ATRC

Healthcare Medical Devices
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

AtriCure to Present at the JMP Securities Life Science Conference

Business Wire May 18, 2017

AtriCure Reports First Quarter 2017 Financial Results

Business Wire May 4, 2017

AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide

Business Wire April 25, 2017

AtriCure to Announce First Quarter 2017 Financial Results

Business Wire April 7, 2017

AtriCure Names Two New Members to its Board of Directors

Business Wire March 21, 2017

AtriCure Names National Principal Investigator for the CONVERGE IDE Clinical Trial

Business Wire March 14, 2017

AtriCure to Present at the Needham & Company’s 16th Annual Healthcare Conference

Business Wire March 10, 2017

15 Biggest Mid-Day Losers For Monday

Benzinga.com  March 6, 2017

Mid-Morning Market Update: Markets Open Lower; Deutsche Bank Plans to Raise Capital

Benzinga.com  March 6, 2017

AtriCure Announces hiring of Senior Vice President of Clinical, Regulatory, and Scientific Affairs

Business Wire March 6, 2017

AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results

Business Wire February 28, 2017

AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016

Business Wire February 3, 2017

AtriCure to Present at the Leerink Partners Global Healthcare Conference

Business Wire January 24, 2017

AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016

Business Wire January 9, 2017

AtriCure to Present at the 35th Annual JP Morgan Healthcare Conference

Business Wire December 15, 2016

AtriCure Names Sven Wehrwein to its Board of Directors

Business Wire November 11, 2016

AtriCure to Present at the Piper Jaffray 28th Annual Healthcare Conference

Business Wire November 7, 2016

AtriCure Announces Approval for the cryoICE™ Platform in Japan

Business Wire November 1, 2016

20 Biggest Mid-Day Gainers For Friday

Benzinga.com  October 28, 2016

Mid-Morning Market Update: Markets Mostly Higher; Mastercard Beats Q3 Views

Benzinga.com  October 28, 2016